Sfoglia per Autore
Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavir
2007-01-01 Gianotti, N; Guffanti, M; Galli, L; Margonato, Alberto; Chiaravalli, G; Bigoloni, A; Lazzarin, A; Castagna, Antonella
First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006)
2007-01-01 Carosi, G.; Quiros roldan, E.; Torti, C.; Antinori, A.; Bevilacqua, M.; Bonadonna, R. C.; Bonfanti, P.; Castagna, Antonella; Cauda, R.; D'arminio monforte, A.; Di Gregorio, P.; Di Perri, G.; Esposito, R.; Fatuzzo, F.; Gervasoni, C.; Giannattasio, C.; Guaraldi, G.; Lazzarin, Adriano; Lo Caputo, S.; Maggi, P.; Mazzotta, F.; Moroni, M.; Prestileo, T.; Ranieri, R.; Rizzardini, G.; Russo, R.; Galli, M.
Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity [9]
2007-01-01 Caumo, Andrea; Guffanti, Monica; Perseghin, Gianluca; Galli, Laura; Lazzarin, Adriano; Luzi, Livio; Castagna, Antonella
Etravirine for the treatment of HIV infection
2008-01-01 Seminari, E.; Castagna, Antonella; Lazzarin, Adriano
HIV-1 replication capacity and genotype changes in patients undergoing treatment interruption or lamivudine monotherapy
2008-01-01 Gianotti, N; Tiberi, S; Menzo, S; Danise, A; Boeri, E; Galli, L; Clementi, Massimo; Lazzarin, A; Castagna, Antonella
Influence of gender in predicting CCR5 coreceptor usage
2008-01-01 Nozza, S; Soria, A; Visco, F; Vinci, C; Cossarini, F; Spagnuolo, V; Barda, B; Torre, L Della; Castagna, A; Lazzarin, A; Galli, L; Tambussi, G
Dynamics of the M184V mutation by allele-specific PCR (AS-PCR) in patients receiving lamivudine or emtricitabine monotherapy or undergoing treatment interruption (TI)
2008-01-01 Bestetti, A; Soria, A; Galli, L; Danise, A; Sala, S; Bossolasco, S; Sampaolo, M; Bigoloni, A; Galli, A; Clementi, M; Lazzarin, A; Castagna, A; Cinque, P
Carotid vessels lesions in experienced HIV-1-infected subjects affected or not by hypertension and/or diabetes mellitus
2008-01-01 Semeraro, G; Guffanti, M; Giusti, Mc; Galli, L; Salpietro, S; Lazzarin, A; Castagna, A
In Vivo Treatment with Fusion Inhibitor Enfuvirtide Leads to Increased IL-12 Production by Autologous in Vitro Activated Monocytes from HIV-infected Individuals
2009-01-01 Vecchi, Andrea; Hasso, Hamid; Galli, Andrea; Castagna, Antonella; Lazzarin, Adriano; Biswas, Priscilla
Survival of HIV-1 Infected Multidrug-Resistant Patients Recycling Enfuvirtide After a Previous Failure
2009-01-01 Cossarini, F; Galli, L; Sagnelli, C; Gianotti, N; Hasson, H; Clementi, Massimo; Soria, A; Salpietro, S; Lazzarin, A; Castagna, Antonella
FAILURE TO DARUNAVIR/RITONAVIR CAN EITHER INCREASE OR DECREASE TIPRANAVIR/RITONAVIR GENOTYPIC RESISTANCE SCORE IN HIGHLY TREATMENT-EXPERIENCED HIV-INFECTED PATIENTS
2009-01-01 Gianotti, N; Spagnuolo, V; Bigoloni, A; Vinci, C; Salpietro, S; Seminari, E; Lazzarin, A; Castagna, A
INCREASED RISK OF DEATH AMONG HIV/HCV CO-INFECTED PATIENTS WITH NON-HODGKIN'S LYMPHOMA
2009-01-01 Gallotta, G; Bossolasco, S; Galli, L; Spagnuolo, Vincenzo; Cinque, P; Sampietro, S; Gianotti, N; Castagna, Antonella; UBERTI FOPPA, Caterina; Lazzarin, Adriano
Italian consensus statement on management of HIV-infected individuals with advanced disease naïve to antiretroviral therapy
2009-01-01 Antinori, A.; Ammassari, A.; Torti, C.; Marconi, P.; Andreoni, M.; Angarano, G.; Bonora, S.; Castagna, Antonella; Cauda, R.; Clerici, M.; D'arminio Monforte, A.; De Luca, A.; Di Perri, G.; Galli, M.; Girardi, E.; Gori, A.; Lazzarin, Adriano; Lo Caputo, S.; Mazzotta, F.; Montella, F.; Mussini, C.; Perno, C. F.; Puoti, M.; Rizzardini, G.; Rusconi, S.; Vullo, V.; Carosi, G.
Raltegravir in treatment nave patients
2009-01-01 Cossarini, F.; Castagna, Antonella; Lazzarin, Adriano
LONG-TERM SURVIVAL AMONG HIV-1 INFECTED PATIENTS WITH AIDS AND NON AIDS RELATED MALIGNANCIES
2009-01-01 Spagnuolo, V; Galli, L; Salpietro, S; Bigoloni, A; Cinque, P; Gianotti, N; Bossolasco, S; Guffanti, M; Fumagalli, L; Lazzarin, A; Castagna, A
THE EFFECT OF HIV-1 IN DECREASING MITOCHONDRIAL DNA IN PERIPHERAL BLOOD MONONUCLEAR CELLS OVERCOMES THE TOXIC EFFECT OF ANTIRETROVIRAL THERAPY (ART)
2009-01-01 Bossolasco, S; Danise, A; Galli, L; Bestetti, A; Galli, A; Lazzarin, A; Castagna, A; Cinque, P
PHENOTYPIC PROFILES OF HIV-1 INTEGRASE GENE EVOLUTION DURING RALTEGRAVIR FAILURE
2009-01-01 Canducci, F; Marinozzi, Mc; Sampaolo, M; Boeri, E; Castagna, A; Gianotti, N; Spagnuolo, V; Baldanti, F; Paolucci, S; Gulminetti, R; Lazzarin, A; Clementi, M
PHARMACOKINETICS AND PHARMACOGENETICS OF MARAVIROC IN THE CLINICAL SETTING
2009-01-01 Siccardi, M; Bonora, S; Nozza, S; Castagna, A; D'Avolio, A; Michelazzo, M; Chiesa, M; Calcagno, A; Lazzarin, A; Di Perri, G
DEVELOPMENT OF ALLELE-SPECIFIC PCR (AS-PCR) ASSAYS TO INVESTIGATE MAJOR HIV RESISTANCE MUTATIONS TO NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTIS) AND NON NUCLEOSIDE RT INHIBITORS (NNRTI)
2009-01-01 Formicola, R; Bestetti, A; Soria, A; Galli, L; Danise, A; Sala, S; Sampaolo, M; Galli, A; Gianotti, N; Clementi, M; Lazzarin, A; Castagna, A; Cinque, P
High plasma levels of parathyroid hormone (PTH) are associated with an increased cardiovascular risk among HIV-infected subjects
2010-01-01 Spagnuolo, V; Galli, L; Salpietro, S; Vinci, C; Cossarini, F; Travi, G; Rubinacci, A; Mignogna, G; Cernuschi, M; Bossolasco, S; Lazzarin, A; Castagna, A
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavir | 1-gen-2007 | Gianotti, N; Guffanti, M; Galli, L; Margonato, Alberto; Chiaravalli, G; Bigoloni, A; Lazzarin, A; Castagna, Antonella | |
First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006) | 1-gen-2007 | Carosi, G.; Quiros roldan, E.; Torti, C.; Antinori, A.; Bevilacqua, M.; Bonadonna, R. C.; Bonfanti, P.; Castagna, Antonella; Cauda, R.; D'arminio monforte, A.; Di Gregorio, P.; Di Perri, G.; Esposito, R.; Fatuzzo, F.; Gervasoni, C.; Giannattasio, C.; Guaraldi, G.; Lazzarin, Adriano; Lo Caputo, S.; Maggi, P.; Mazzotta, F.; Moroni, M.; Prestileo, T.; Ranieri, R.; Rizzardini, G.; Russo, R.; Galli, M. | |
Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity [9] | 1-gen-2007 | Caumo, Andrea; Guffanti, Monica; Perseghin, Gianluca; Galli, Laura; Lazzarin, Adriano; Luzi, Livio; Castagna, Antonella | |
Etravirine for the treatment of HIV infection | 1-gen-2008 | Seminari, E.; Castagna, Antonella; Lazzarin, Adriano | |
HIV-1 replication capacity and genotype changes in patients undergoing treatment interruption or lamivudine monotherapy | 1-gen-2008 | Gianotti, N; Tiberi, S; Menzo, S; Danise, A; Boeri, E; Galli, L; Clementi, Massimo; Lazzarin, A; Castagna, Antonella | |
Influence of gender in predicting CCR5 coreceptor usage | 1-gen-2008 | Nozza, S; Soria, A; Visco, F; Vinci, C; Cossarini, F; Spagnuolo, V; Barda, B; Torre, L Della; Castagna, A; Lazzarin, A; Galli, L; Tambussi, G | |
Dynamics of the M184V mutation by allele-specific PCR (AS-PCR) in patients receiving lamivudine or emtricitabine monotherapy or undergoing treatment interruption (TI) | 1-gen-2008 | Bestetti, A; Soria, A; Galli, L; Danise, A; Sala, S; Bossolasco, S; Sampaolo, M; Bigoloni, A; Galli, A; Clementi, M; Lazzarin, A; Castagna, A; Cinque, P | |
Carotid vessels lesions in experienced HIV-1-infected subjects affected or not by hypertension and/or diabetes mellitus | 1-gen-2008 | Semeraro, G; Guffanti, M; Giusti, Mc; Galli, L; Salpietro, S; Lazzarin, A; Castagna, A | |
In Vivo Treatment with Fusion Inhibitor Enfuvirtide Leads to Increased IL-12 Production by Autologous in Vitro Activated Monocytes from HIV-infected Individuals | 1-gen-2009 | Vecchi, Andrea; Hasso, Hamid; Galli, Andrea; Castagna, Antonella; Lazzarin, Adriano; Biswas, Priscilla | |
Survival of HIV-1 Infected Multidrug-Resistant Patients Recycling Enfuvirtide After a Previous Failure | 1-gen-2009 | Cossarini, F; Galli, L; Sagnelli, C; Gianotti, N; Hasson, H; Clementi, Massimo; Soria, A; Salpietro, S; Lazzarin, A; Castagna, Antonella | |
FAILURE TO DARUNAVIR/RITONAVIR CAN EITHER INCREASE OR DECREASE TIPRANAVIR/RITONAVIR GENOTYPIC RESISTANCE SCORE IN HIGHLY TREATMENT-EXPERIENCED HIV-INFECTED PATIENTS | 1-gen-2009 | Gianotti, N; Spagnuolo, V; Bigoloni, A; Vinci, C; Salpietro, S; Seminari, E; Lazzarin, A; Castagna, A | |
INCREASED RISK OF DEATH AMONG HIV/HCV CO-INFECTED PATIENTS WITH NON-HODGKIN'S LYMPHOMA | 1-gen-2009 | Gallotta, G; Bossolasco, S; Galli, L; Spagnuolo, Vincenzo; Cinque, P; Sampietro, S; Gianotti, N; Castagna, Antonella; UBERTI FOPPA, Caterina; Lazzarin, Adriano | |
Italian consensus statement on management of HIV-infected individuals with advanced disease naïve to antiretroviral therapy | 1-gen-2009 | Antinori, A.; Ammassari, A.; Torti, C.; Marconi, P.; Andreoni, M.; Angarano, G.; Bonora, S.; Castagna, Antonella; Cauda, R.; Clerici, M.; D'arminio Monforte, A.; De Luca, A.; Di Perri, G.; Galli, M.; Girardi, E.; Gori, A.; Lazzarin, Adriano; Lo Caputo, S.; Mazzotta, F.; Montella, F.; Mussini, C.; Perno, C. F.; Puoti, M.; Rizzardini, G.; Rusconi, S.; Vullo, V.; Carosi, G. | |
Raltegravir in treatment nave patients | 1-gen-2009 | Cossarini, F.; Castagna, Antonella; Lazzarin, Adriano | |
LONG-TERM SURVIVAL AMONG HIV-1 INFECTED PATIENTS WITH AIDS AND NON AIDS RELATED MALIGNANCIES | 1-gen-2009 | Spagnuolo, V; Galli, L; Salpietro, S; Bigoloni, A; Cinque, P; Gianotti, N; Bossolasco, S; Guffanti, M; Fumagalli, L; Lazzarin, A; Castagna, A | |
THE EFFECT OF HIV-1 IN DECREASING MITOCHONDRIAL DNA IN PERIPHERAL BLOOD MONONUCLEAR CELLS OVERCOMES THE TOXIC EFFECT OF ANTIRETROVIRAL THERAPY (ART) | 1-gen-2009 | Bossolasco, S; Danise, A; Galli, L; Bestetti, A; Galli, A; Lazzarin, A; Castagna, A; Cinque, P | |
PHENOTYPIC PROFILES OF HIV-1 INTEGRASE GENE EVOLUTION DURING RALTEGRAVIR FAILURE | 1-gen-2009 | Canducci, F; Marinozzi, Mc; Sampaolo, M; Boeri, E; Castagna, A; Gianotti, N; Spagnuolo, V; Baldanti, F; Paolucci, S; Gulminetti, R; Lazzarin, A; Clementi, M | |
PHARMACOKINETICS AND PHARMACOGENETICS OF MARAVIROC IN THE CLINICAL SETTING | 1-gen-2009 | Siccardi, M; Bonora, S; Nozza, S; Castagna, A; D'Avolio, A; Michelazzo, M; Chiesa, M; Calcagno, A; Lazzarin, A; Di Perri, G | |
DEVELOPMENT OF ALLELE-SPECIFIC PCR (AS-PCR) ASSAYS TO INVESTIGATE MAJOR HIV RESISTANCE MUTATIONS TO NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTIS) AND NON NUCLEOSIDE RT INHIBITORS (NNRTI) | 1-gen-2009 | Formicola, R; Bestetti, A; Soria, A; Galli, L; Danise, A; Sala, S; Sampaolo, M; Galli, A; Gianotti, N; Clementi, M; Lazzarin, A; Castagna, A; Cinque, P | |
High plasma levels of parathyroid hormone (PTH) are associated with an increased cardiovascular risk among HIV-infected subjects | 1-gen-2010 | Spagnuolo, V; Galli, L; Salpietro, S; Vinci, C; Cossarini, F; Travi, G; Rubinacci, A; Mignogna, G; Cernuschi, M; Bossolasco, S; Lazzarin, A; Castagna, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile